An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.
A team of researchers has discovered a non-invasive biomarker that could aid with earlier diagnosis of breast cancer, the most common cancer among women, which will likely affect one in 13 women during their lives.
Dr. Myles Wolf will lead the institutions’ largest clinical and academic department, overseeing 16 divisions and nearly 2,250 physicians and scientists.
An international phase 3 clinical trial found that a new targeted treatment, given in combination with a standard chemotherapy, extended survival for select patients with advanced gastric or gastroesophageal junction cancer.
The hackathons, run by Entrepreneurship at Cornell, are open to undergraduate and graduate students from any field and major and take place from Friday evenings through Sunday afternoon.
Twenty seniors in the Milstein Program in Technology & Humanity will graduate this year with degrees in everything from biology to linguistics to computer science to physics.
A novel combination of artificial intelligence and production techniques could change the future of nanomedicine, according to Cornell researchers using a new $3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.
Cornell experts have launched the Aging and Climate Change Clearinghouse to promote research, policies and activism addressing the need to protect vulnerable older adults in the face of climate challenges.
Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.